European Journal of Biochemistry · 1999 · 46 citations · 26 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyEnzymologyMass Spectrometric AnalysisGastrointestinal PharmacologyIon ChromatographyBioactivityBioactivity ScreeningBioactivity TestingBiological Activity FeaturesCholecystokinin PharmacologyMatrix-assisted Laser Desorption/ionizationPeptide Mass Spectrometry
Cholecystokinin (CCK) exists in multiple molecular forms with different polypeptide lengths and the absence or presence of sulphation. We have isolated sulphated and nonsulphated forms of CCK-58 from porcine intestine and have determined their bioactivities in a guinea-pig gallbladder contraction assay. Both forms co-eluted in cation-exchange chromatography and in several rounds of reverse-phase (RP)-HPLC, but separated upon RP-HPLC using a water/acetonitrile system with heptafluorobutyric acid as counter ion. Nonsulphated CCK-58 was the form detected by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry because of desulphation in that process. The biological activity of CCK-58 and CCK-33 is equipotent, although the kinetics of the response differ. Sulphated CCK-58 was found to be 35 times more potent than nonsulphated CCK-58. In contrast, sulphated CCK-8 is 150 times more potent than nonsulphated CCK-8, and for sulphated and nonsulphated CCK-33, the activities differ by a factor of 100. This type of correlation indicates that the N-terminal end of CCK-58 partially compensates for the decrease in activity arising from the lack of sulphated tyrosine. Given its fairly high bioactivity, nonsulphated CCK-58 may have a physiological significance.
26
New peptide in the vertebrate CNS reacting with antigastrin antibodies
J.J. Vanderhaeghen, J. C. SIGNEAU, W Gepts · Nature · 1975 · 759 citations
Accurate measurement of cholecystokinin in plasma
Jens F. Rehfeld · Clinical Chemistry · 1998 · 319 citations